Cleared Traditional

K904004 - AMRESCOCREAT KINASE REAGENT 7716/17

K904004 is the FDA 510(k) clearance for AMRESCOCREAT KINASE REAGENT 7716/17 by Amresco, Inc.. It is a Class 2 Chemistry device (product code CGS) cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K904004 · Amresco, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1990
Decision
104d
Days
Class 2
Risk

K904004 is an FDA 510(k) clearance for the AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Amresco, Inc. (Solon, US). The FDA issued a Cleared decision on December 11, 1990 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Amresco, Inc. devices

Submission Details

510(k) Number K904004 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 1990
Decision Date December 11, 1990
Days to Decision 104 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 88d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 100
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K904004.
CREATINE KINASE MB TEST ITEM NUMBER 5A46
K914361 · Em Diagnostic Systems, Inc. · Dec 1991
RAICHEM(TM) CREATINE KINASE-MB REAGENT
K913398 · Reagents Applications, Inc. · Sep 1991
RAICHEM CREATINE KINASE REAGENT, OPTIMIZED UV
K905084 · Reagents Applications, Inc. · Dec 1990
CREATINE PHOSPHOKINASE
K903775 · Amresco, Inc. · Oct 1990
REFLOTRON CREATINE KINASE TEST TABS
K904102 · Boehringer Mannheim Corp. · Sep 1990
CREATINE KINASE TEST (CK) ITEM NUMBER 65411
K903333 · Em Diagnostic Systems, Inc. · Aug 1990